Certara CERT 深 沪
已收盘 08-01 16:00:00 美东时间
9.54
-0.300
-3.05%
华盛通- 最 高9.715
- 今 开9.69
- 成交量 193.10万股
- 最 低 9.36
- 昨 收 9.84
- 总市值 15.45亿
- 52周最高 15.69
- 市盈率 静 --
- 换手率 1.19%
- 52周最低 8.635
- 委 比 -5.52%
- 总股本 1.62亿
- 历史最高 45.48
- 量 比 1.42
- 振 幅 3.61%
- 历史最低 8.635
- 每 手 1
- 风险率 1.30%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美方利用微软Exchange漏洞攻击我军工企业！详情披露
据中国网络空间安全协会微信公众号消息，国家互联网应急中心(CNCERT)监测发现，近年来，美国情报机构将网络攻击窃密的重点目标瞄准我高科技军工类的高校、科研院所...
08-01 10:36
Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform
Certara, Inc. appoints Christopher Bouton, Ph.D., as Chief Technology Officer to lead the development of a next-generation AI and biosimulation-enabled drug development platform. Bouton, formerly founder and CEO of Vyasa Analytics (acquired by Certara in 2022), brings expertise in AI, drug discovery, and development. His leadership has advanced Certara's AI-driven biosimulation and virtual trials, enhancing efficiency and success rates in bringin...
07-31 20:15
A Look at Waystar Holding's Upcoming Earnings Report
Waystar Holding (NASDAQ:WAY) will release its quarterly earnings report on Wedn...
07-30 03:01
星巴克在欧洲推出可回收且可家庭堆肥的环保外带杯 原材料采用芬林纸板产品
（来源：中纸网） 星巴克与合作伙伴共同研发了一款全新的环保外带杯，芬林纸板参与了此次重新设计项目。这款外带杯不仅易于回收，还可在家庭环境中进行堆肥处理...
07-19 11:06
dynaCERT’s HydraGEN™ Technology Pioneers Emission Reduction at French Port
dynaCERT ( ($TSE:DYA) ) has issued an update. dynaCERT has announced the deploy...
07-17 17:33
Simulations Plus Sees Weaker Demand Persist, Outlook Softens
Simulations Plus Inc. reported lower than expected sales and reduced guidance due to cautious biopharma spending.
07-16 01:56
OFS Capital Estimates Q2 2025 NAV At $10.86–$10.96; Net Investment Income Per Share Estimated At $0.23–$0.27 vs. $0.26 in Q1
OFS Capital Corporation (NASDAQ:OFS) ("OFS Capital," "we," "us," or "our") today announced preliminary estimates of certain financial results for the quarter ended June 30, 2025.PRELIMINARY ESTIMATES OF CERTAIN FINANCIAL
07-15 20:18
Keybanc Maintains Overweight on Certara, Lowers Price Target to $15
Keybanc analyst Scott Schoenhaus maintains Certara (NASDAQ:CERT) with a Overweight and lowers the price target from $18 to $15.
07-14 20:10
Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025
Certara, Inc. announced it will release its second quarter 2025 financial results after market close on August 6, 2025. Management will host a conference call at 5:00PM ET to discuss the results. Investors can register online in advance and access a live or archived webcast on Certara's investor website. Certara is a global leader in model-informed drug development, serving biopharmaceutical companies and regulatory agencies worldwide. For more i...
07-09 20:15
Certara 宣布扩展与默克的临床技术合作
通过扩展 Certara Pinnacle 21®（P21）企业软件平台应用，优化临床数据流程以提升速度与质量 宾夕法尼亚州拉德诺2025年7月8日 /美通社...
07-09 09:20
